Sacramento, Calif.-based Sutter Health, has expanded its partnership with specialty pharmacy company Shields Health Solutions.

Independent pharmacies are fighting to stay profitable as pharmacy benefit managers favor big chains, KFF Health News reported Oct. 24. 

The Institute for Safe Medication Practices has raised concerns about vaccination-related errors, particularly with newer vaccines, as highlighted in its 2022-2023 Bi-Annual report. 

In April, the American Society of Health-System Pharmacists reported 323 ongoing drug shortages — the highest number since the organization began tracking them in 2001. The number has since fallen to 277.

A recent investigation by The New York Times revealed that two pharmaceutical companies, Eisai and Eli Lilly, withheld critical genetic risk information from volunteers during clinical trials for Alzheimer's drugs, Leqembi and Kisunla. 

More than 7,000 bottles of duloxetine, a generic version of antidepressant Cymbalta, have been recalled by the FDA due to the presence of N-nitroso-duloxetine, a chemical that is a suspected carcinogen. 

Novo Nordisk has requested that the FDA prohibit compounding pharmacies from producing unapproved versions of its popular weight loss and diabetes drugs, Wegovy and Ozempic, CNBC reported Oct. 23.

Occupational burnout costs a hospital with 50 pharmacists an estimated $269,580 in turnover expenses, according to the American Society of Health-System Pharmacists' burnout calculator. 

In 2023, the top 10 drugs purchased under the 340B Drug Pricing Program accounted for roughly one-third of the program's total spending, according to a Health Resources and Services Administration news release. 

The FDA approved Pfizer's Abrysvo, the first and only RSV vaccine for adults aged 18 to 59 who are at increased risk of severe respiratory illness caused by RSV.